There have been few epidemiological data on gastroenteropancreatic neuroendocrine tumors (GEPNETs) in Japan. First, we reported the epidemiology of pancreatic endocrine tumors (PNETs) and gastrointestinal neuroendocrine tumors (GI-NETs) in Japan in 2005. Next, we conducted the second survey regarding with GEPNETs patients who received treatment in 2010. A total of 3,379 individuals received treatment for PNETs in 2010. The number of patients in 2010 was an increase of about 1.2 times as compared to that in 2005. Non-functioning tumor (NF)-PNET constituted 64.5%, followed by insulinoma (20.9%) and gastrinoma (8.2%). On the other hand, an estimated 8,088 patients received treatment for GI-NETs. The number of patients in 2010 was an increase of about 1.8 times as compared to that in 2005. The locations of GI-NETs varied: foregut, 26.1%; midgut, 3.6%; and hindgut, 70.3%. The frequency of carcinoid syndrome in GI-NETs was only 3.2%. The results show that the number of Japanese patients with GEP-NET in 2010 was an increase compared in 2005.
抄録全体を表示